These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 8940979)
1. Serodiagnosis of cutaneous leishmaniasis: assessment of an enzyme-linked immunosorbent assay using a peptide sequence from gene B protein. Jensen AT; Gaafar A; Ismail A; Christensen CB; Kemp M; Hassan AM; Kharazmi A; Theander TG Am J Trop Med Hyg; 1996 Nov; 55(5):490-5. PubMed ID: 8940979 [TBL] [Abstract][Full Text] [Related]
2. Serodiagnosis of Leishmania donovani infections: assessment of enzyme-linked immunosorbent assays using recombinant L. donovani gene B protein (GBP) and a peptide sequence of L. donovani GBP. Jensen AT; Gasim S; Moller T; Ismail A; Gaafar A; Kemp M; el Hassan AM; Kharazmi A; Alce TM; Smith DF; Theander TG Trans R Soc Trop Med Hyg; 1999; 93(2):157-60. PubMed ID: 10450438 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of recombinant gp63, the major Leishmania surface glycoprotein, as a diagnostic molecule for leishmaniasis in vervet monkeys. Gicheru MM; Olobo JO Acta Trop; 1994 Dec; 58(3-4):345-8. PubMed ID: 7709873 [No Abstract] [Full Text] [Related]
4. Synthetic peptide-based enzyme-linked immunosorbent assay for serodiagnosis of visceral leishmaniasis. Fargeas C; Hommel M; Maingon R; Dourado C; Monsigny M; Mayer R J Clin Microbiol; 1996 Feb; 34(2):241-8. PubMed ID: 8788994 [TBL] [Abstract][Full Text] [Related]
5. Specific K39 antibody response and its persistence after treatment in patients with imported leishmaniasis. Reiter-Owona I; Rehkaemper-Schaefer C; Arriens S; Rosenstock P; Pfarr K; Hoerauf A Parasitol Res; 2016 Feb; 115(2):761-9. PubMed ID: 26508007 [TBL] [Abstract][Full Text] [Related]
6. Humoral and cellular immune responses to synthetic peptides of the Leishmania donovani kinetoplastid membrane protein-11. Jensen AT; Gasim S; Ismail A; Gaafar A; Kurtzhals JA; Kemp M; El Hassan AM; Kharazmi A; Theander TG Scand J Immunol; 1998 Jul; 48(1):103-9. PubMed ID: 9714418 [TBL] [Abstract][Full Text] [Related]
7. Heterologous protection by Leishmania donovani for Leishmania major infections in the vervet monkey model of the disease. Gicheru MM; Olobo JO; Anjili CO Exp Parasitol; 1997 Feb; 85(2):109-16. PubMed ID: 9030661 [TBL] [Abstract][Full Text] [Related]
8. Cloning and expression of Leishmania major superoxide dismutase B1: A potential target antigen for serodiagnosis of Leishmaniasis. Yeganeh F; Barkhordari F; Omidi M; Samiei A; Adeli A; Mahboudi F; Kamali-Sarvestani E Iran J Immunol; 2009 Sep; 6(3):130-40. PubMed ID: 19801786 [TBL] [Abstract][Full Text] [Related]
9. Antibody response against a Leishmania donovani amastigote-stage-specific protein in patients with visceral leishmaniasis. Ghedin E; Zhang WW; Charest H; Sundar S; Kenney RT; Matlashewski G Clin Diagn Lab Immunol; 1997 Sep; 4(5):530-5. PubMed ID: 9302200 [TBL] [Abstract][Full Text] [Related]
10. Dichotomy of the human T cell response to Leishmania antigens. I. Th1-like response to Leishmania major promastigote antigens in individuals recovered from cutaneous leishmaniasis. Kemp M; Hey AS; Kurtzhals JA; Christensen CB; Gaafar A; Mustafa MD; Kordofani AA; Ismail A; Kharazmi A; Theander TG Clin Exp Immunol; 1994 Jun; 96(3):410-5. PubMed ID: 8004809 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of a hypothetical protein for serodiagnosis and as a potential marker for post-treatment serological evaluation of tegumentary leishmaniasis patients. Lima MP; Costa LE; Duarte MC; Menezes-Souza D; Salles BCS; de Oliveira Santos TT; Ramos FF; Chávez-Fumagalli MA; Kursancew ACS; Ambrósio RP; Roatt BM; Machado-de-Ávila RA; Gonçalves DU; Coelho EAF Parasitol Res; 2017 Apr; 116(4):1197-1206. PubMed ID: 28150041 [TBL] [Abstract][Full Text] [Related]
12. Serological evaluation of experimentally infected dogs by LicTXNPx-ELISA and amastigote-flow cytometry. Silvestre R; Santarém N; Cunha J; Cardoso L; Nieto J; Carrillo E; Moreno J; Cordeiro-da-Silva A Vet Parasitol; 2008 Nov; 158(1-2):23-30. PubMed ID: 18848397 [TBL] [Abstract][Full Text] [Related]
13. Leishmania promastigote membrane antigen-based enzyme-linked immunosorbent assay and immunoblotting for differential diagnosis of Indian post-kala-azar dermal leishmaniasis. Saha S; Mazumdar T; Anam K; Ravindran R; Bairagi B; Saha B; Goswami R; Pramanik N; Guha SK; Kar S; Banerjee D; Ali N J Clin Microbiol; 2005 Mar; 43(3):1269-77. PubMed ID: 15750095 [TBL] [Abstract][Full Text] [Related]
14. Diagnosis of visceral leishmaniasis by enzyme-linked immunosorbent assay using urine samples. Islam MZ; Itoh M; Shamsuzzaman SM; Mirza R; Matin F; Ahmed I; Shamsuzzaman Choudhury AK; Hossain MA; Qiu XG; Begam N; Furuya M; Leafasia JL; Hashiguchi Y; Kimura E Clin Diagn Lab Immunol; 2002 Jul; 9(4):789-94. PubMed ID: 12093674 [TBL] [Abstract][Full Text] [Related]
15. [Role of three ELISA tests using promastigote homogenates of Leishmania braziliensis, L. amazonensis and L. guyanensis in the diagnosis of tegumentary leishmaniasis]. Gil JF; Hoyos CL; Cimino RO; Krolewiecki AJ; López Quiroga I; Cajal SP; Juárez M; García Bustos MF; Mora MC; Marco JD; Nasser JR Medicina (B Aires); 2011; 71(5):420-8. PubMed ID: 22057166 [TBL] [Abstract][Full Text] [Related]
16. First Serological Study Revealing High Humoral Response and Evidence for Antigenic Heterogeneity in Deepachandi B; Weerasinghe S; Ranasinghe S; Andrahennadi TP; Wickramanayake MN; Siri S; Karunaweera N; Chandrasekharan V; Chatterjee M; Soysa P; Siriwardana Y Biomed Res Int; 2020; 2020():5271657. PubMed ID: 33145352 [TBL] [Abstract][Full Text] [Related]
17. Antigenaemia and antibody response to Leishmania donovani stage-specific antigens and rk39 antigen in human immunodeficiency virus-infected patients. Malla N; Sengupta C; Dubey ML; Sud A; Ansari NA; Salotra P Br J Biomed Sci; 2003; 60(4):210-6. PubMed ID: 14725337 [TBL] [Abstract][Full Text] [Related]
18. Use of Recombinant Antigens for Sensitive Serodiagnosis of American Tegumentary Leishmaniasis Caused by Different Leishmania Species. Sato CM; Sanchez MC; Celeste BJ; Duthie MS; Guderian J; Reed SG; de Brito ME; Campos MB; de Souza Encarnação HV; Guerra J; de Mesquita TG; Pinheiro SK; Ramasawmy R; Silveira FT; de Assis Souza M; Goto H J Clin Microbiol; 2017 Feb; 55(2):495-503. PubMed ID: 27927927 [TBL] [Abstract][Full Text] [Related]
19. Measurement of serum antibodies against native Leishmania gp63 distinguishes between ongoing and previous L. donovani infection. Okong'o-Odera EA; Kurtzhals JA; Hey AS; Kharazmi A APMIS; 1993 Aug; 101(8):642-6. PubMed ID: 8105816 [TBL] [Abstract][Full Text] [Related]
20. Vaccination of the Leishmania major susceptible BALB/c mouse. I. The precise selection of peptide determinant influences CD4+ T cell subset expression. Soares LR; Sercarz EE; Miller A Int Immunol; 1994 May; 6(5):785-94. PubMed ID: 7521670 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]